[1]
Pasek, M. et al. 2026. Comparison of the Efficacy and Safety between Adjuvant and Palliative Anti-PD-1 Treatment of Stage 4 Oligometastatic Melanoma. Dermatology Practical & Conceptual. 16, 1 (Jan. 2026), 6483. DOI:https://doi.org/10.5826/dpc.1601a6483.